[Interpretation of the Chinese guideline for diagnosis and management of drug-induced liver injury (2023 version)].

Zhonghua Gan Zang Bing Za Zhi

Renji Hospital, School of Medicine, Shanghai Jiao Tong University Shanghai Institute of Digestive Disease, Shanghai Research Center of Fatty Liver Disease, Shanghai 200001, China.

Published: April 2024

Drug can cause almost all known types of acute, subacute, and chronic liver injuries. Drug-induced liver injury (DILI) is an important cause of unexplained liver injury in clinical practice. Correct diagnosis of DILI is challenging due to lack of specific diagnostic biomarkers, especially in patients with pre-existing liver disease and multiple concomitant drugs. A comprehensive understanding of the risk factors, clinical features, and prognosis of liver injury caused by different drugs will help physicians to recognize, diagnose, and manage it timely. Although the guideline was developed based on evidence-based medicine provided by the latest studies, there is limited high-quality evidence in the field of DILI. Therefore, this guideline should be interpreted with caution, and physicians should adopt an optimal diagnostic and therapeutic strategy for individual patients within the framework of the guideline.

Download full-text PDF

Source
http://dx.doi.org/10.3760/cma.j.cn501113-20230829-00077DOI Listing

Publication Analysis

Top Keywords

liver injury
16
drug-induced liver
8
liver
6
[interpretation chinese
4
guideline
4
chinese guideline
4
guideline diagnosis
4
diagnosis management
4
management drug-induced
4
injury
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!